机构：[1]Shanghai Chest Hospital,Shanghai/CN[2]Cancer Hospital of the University of Chinese Academy ofSciences (Zhejiang Cancer Hospital), Hangzhou/CN,浙江省肿瘤医院[3]The First AffiliatedHospital of Zhengzhou University, Zhengzhou/CN,[4]The First AffiliatedHospital, College of Medicine, Zhejiang University, Hangzhou/CN,[5]HenanProvincial People’s Hospital, Zhengzhou/CN,[6]Jilin Cancer Hospital,Changchun/CN,[7]Union Hospital affiliated to Tongji Medical College ofHuazhong University of Science and Technology, Wuhan/CN,华中科技大学同济医学院附属协和医院[8]The ThirdXiangya Hospital of Central South University, Changsha/CN,[9]Taizhouhospital of Zhejiang Province, Linhai/CN,[10]The First Affiliated Hospital ofWenzhou Medical University, Wenzhou/CN,[11]General Hospital of NingxiaMedical University, Yinchuan/CN,[12]West China School of Medicine/WestChina Hospital of Sichuan University, Chengdu/CN,[13]The SecondAffiliated Hospital of Medical College of Zhejiang University, Hangzhou/CN,[14]Dongguan People’s Hospital, Dongguan/CN,[15]Harbin MedicalUniversity Cancer Hospital, Harbin/CN,[16]Fuzhou Pulmonary Hospital ofFujian, Fuzhou/CN,[17]The Second Affiliated Hospital of Anhui MedicalUniversity, Hefei/CN,[18]The Fourth Hospital of Hebei Medical Universityand Hebei Cancer Hospital, Shijiazhuang/CN,河北医科大学第四医院[19]The First AffiliatedHospital with Nanjing Medical University, Jiangsu Province Hospital,Nanjing/CN,江苏省人民医院[20]The First Affiliated Hospital of Anhui Medical University,Hefei/CN,[21]Huzhou Central Hospital, Huzhou/CN,[22]Beijing ChestHospital, Capital Medical University, Beijing/CN,[23]Peking UniversityCancer Hospital, Beijing Cancer Hospital, Beijing/CN,[24]Tangshanpeople’s Hospital, Tangshan/CN,[25]Fujian Cancer Hospital, Fuzhou/CN,[26]The First Hospital of China Medical University, Shenyang/CN,[27]AirForce Medical University of PLA, the Fourth Military Medical University,Xi’an/CN,[28]The First Affiliated Hospital of University of science andtechnology of China, Anhui provincial hospital, Hefei/CN,[29]TianjinMedical University General Hospital, Tianjin/CN,[30]The Guangxi MedicalUniversity Cancer Hospital, Guangxi Cancer Hospital, Nanning/CN,[31]Hebei Chest Hospital, Shijiazhuang/CN,[32]The first hospital of JilinUniversity, Changchun/CN,[33]The First Affiliated Hospital of BengbuMedical College, Bengbu/CN,[34]Xiangyang Central Hospital, Xiangyang/CN,[35]The Affiliated Hospital of Qingdao University, Qingdao/CN,[36]Chifeng Municipal Hospital, Chifeng/CN,[37]Shijiazhuang people’sHospital, Shijiazhuang/CN,[38]Xuanwu Hospital affiliated to CapitalMedical University, Beijing/CN,首都医科大学宣武医院胸外科外科系统[39]Yunnan Cancer Hospital /the ThirdAffiliated Hospital of Kunming Medical University, Kunming/CN,[40]Shengjing Hospital of China Medical University, Shenyang/CN,中国医科大学附属盛京医院中国医科大学盛京医院[41]Thefirst Medical Centre of Chinese PLA General Hospital, Beijing/CN,[42]Affiliated Hospital of Hebei University, Baoding/CN,河北大学附属医院[43]AffiliatedHospital of Chengde Medical College, Chengde/CN,[44]Liaoning CancerHospital & Institute, Shenyang/CN,[45]Jinling Hospital Nanjing UniversitySchool of Medicine, Nanjing/CN,[46]Cancer Hospital Affiliated toChongqing University, Chongqing Cancer Hospital, Chongqing/CN
S. Lu,Y. Zhang,G. Zhang,et al.A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs[J].JOURNAL OF THORACIC ONCOLOGY.2022,17(9):S469-S469.
APA：
S. Lu,Y. Zhang,G. Zhang,J. Zhou,S. Cang...&S. Zhang.(2022).A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs.JOURNAL OF THORACIC ONCOLOGY,17,(9)
MLA：
S. Lu,et al."A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs".JOURNAL OF THORACIC ONCOLOGY 17..9(2022):S469-S469
医学